Vigilare Wealth Management Pa Vmed Inc. Transaction History

Vigilare Wealth Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$1.16 - $2.5 $15,659 - $33,750	-13,500 Closed	0 $0
Q4 2021 Jan 07, 2022	SELL	$2.46 - $8.74 $126,690 - $450,110	-51,500 Reduced 79.23%	13,500 $33,000
Q3 2021 Oct 19, 2021	SELL	$5.1 - $9.39 $125,969 - $231,933	-24,700 Reduced 27.54%	65,000 $555,000
Q2 2021 Jul 16, 2021	SELL	$3.95 - $6.88 $48,585 - $84,624	-12,300 Reduced 12.06%	89,700 $574,000
Q1 2021 Apr 29, 2021	SELL	$2.01 - $5.55 $170,648 - $471,195	-84,900 Reduced 45.43%	102,000 $453,000

Q4 2020 Jan 14, 2021	BUY	$1.73 - $2.13 $53,457 - $65,817	30,900 Added 19.81%	186,900 $396,000
Q3 2020 Oct 15, 2020	BUY	$1.76 - $2.17 $62,128 - $76,601	35,300 Added 29.25%	156,000 $278,000
Q2 2020 Jul 20, 2020	BUY	$1.75 - $2.65 $73,500 - $111,300	42,000 Added 53.37%	120,700 $255,000
Q1 2020 May 04, 2020	BUY	$1.15 - $3.29 $79,005 - $226,023	68,700 Added 687.0%	78,700 $156,000
Q4 2019 Feb 13, 2020	BUY	$0.84 - $1.2 $8,400 - $12,000	10,000 New	10,000 $15,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $64.6M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.